berberine has been researched along with Diffuse Large B-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Gao, X; Hu, H; Hu, K; Jia, X; Li, B; Lu, Y; Peng, Y; Shi, J; Song, D; Wang, G; Wu, X; Xu, Z; Yi, H; Zhang, H; Zhang, Q; Zhu, H; Zhu, W | 1 |
| Cai, Y; Chen, X; Ding, M; Hu, S; Liu, J; Ren, S; Wang, X; Zhan, L; Zhao, Y; Zhou, X | 1 |
| Chen, SJ; Fei, XC; Gale, RP; Janin, A; Jiang, XF; Li, B; Wang, CF; Wang, L; Xiong, J; Zhao, WL; Zhao, Y; Zheng, Z | 1 |
3 other study(ies) available for berberine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.
Topics: Apoptosis; Berberine; Cell Line, Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Signaling System; Oxidative Stress; Reactive Oxygen Species | 2023 |
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Berberine; CD47 Antigen; Genes, myb; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred BALB C; Middle Aged | 2021 |
MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma.
Topics: Berberine; Cell Line, Tumor; Choline; Choline-Phosphate Cytidylyltransferase; Humans; Lymphoma, Large B-Cell, Diffuse; Mitophagy; Proto-Oncogene Proteins c-myc | 2017 |